{"id":"cannabis-medical","safety":{"commonSideEffects":[{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Dry mouth"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Cognitive impairment"},{"rate":null,"effect":"Anxiety or paranoia"}]},"_chembl":{"chemblId":"CHEMBL2108889","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Cannabis contains multiple cannabinoids, primarily THC and CBD, which bind to CB1 receptors in the central nervous system and CB2 receptors in peripheral tissues and immune cells. These interactions modulate neurotransmitter release, reduce inflammatory signaling, and alter pain perception and nausea pathways. The specific therapeutic effects depend on the cannabinoid profile and route of administration.","oneSentence":"Medical cannabis modulates the endocannabinoid system through cannabinoid receptors (CB1 and CB2) to produce therapeutic effects including pain relief, anti-inflammation, and symptom management.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:48:43.206Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic pain"},{"name":"Chemotherapy-induced nausea and vomiting"},{"name":"Multiple sclerosis-related spasticity"},{"name":"Epilepsy"}]},"trialDetails":[{"nctId":"NCT06418204","phase":"","title":"Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-01-30","conditions":"Breast Carcinoma, Colorectal Carcinoma, Lung Non-Small Cell Carcinoma","enrollment":2000},{"nctId":"NCT05639556","phase":"","title":"Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2023-04-20","conditions":"Cystic Fibrosis","enrollment":300},{"nctId":"NCT07471347","phase":"NA","title":"Exploring The Effect Of Cannabidiol On Cannabis Tolerance Using A Novel Vaporiser Device In Heavy Users (Stage 1)","status":"NOT_YET_RECRUITING","sponsor":"King's College London","startDate":"2026-03","conditions":"Cannabis Intoxication","enrollment":10},{"nctId":"NCT04495725","phase":"NA","title":"Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain","status":"COMPLETED","sponsor":"Vireo Health","startDate":"2020-10-06","conditions":"Opioid Use, Marijuana, Chronic Pain","enrollment":270},{"nctId":"NCT03431363","phase":"","title":"Medical Cannabis During Chemoradiation for Head and Neck Cancer","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-05-18","conditions":"Head and Neck Cancer","enrollment":30},{"nctId":"NCT04989205","phase":"","title":"Community Based Cannabis Cessation Program","status":"COMPLETED","sponsor":"Sorlandet Hospital HF","startDate":"2013-06-02","conditions":"Cannabis Use","enrollment":102},{"nctId":"NCT07398365","phase":"","title":"Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2024-04-03","conditions":"Bipolar Affective Disorder, Schizophrenia Disorders, Depression Disorders","enrollment":100},{"nctId":"NCT07374939","phase":"PHASE2","title":"Medical Cannabis for Nausea in Patients Receiving Moderately or Highly Emetogenic Chemotherapy","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-03-01","conditions":"Nausea and Vomiting Chemotherapy-Induced","enrollment":50},{"nctId":"NCT07362407","phase":"","title":"Analysis of the Therapeutic and Clinical Profile of Cannabinoid Treatments: A Real-World Study","status":"NOT_YET_RECRUITING","sponsor":"Santa Catarina Federal University","startDate":"2026-02","conditions":"Chronic Pain, Depression Disorders, Anxiety Disorders","enrollment":384},{"nctId":"NCT06878417","phase":"NA","title":"Cannabinoids for Osteoarthritis Pain Effectiveness Trial","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-01-15","conditions":"Osteoarthritis of Knee, Osteoarthritis Hip","enrollment":100},{"nctId":"NCT05615389","phase":"PHASE1, PHASE2","title":"Pilot Study of MC in Paediatric Palliative Care","status":"RECRUITING","sponsor":"Murdoch Childrens Research Institute","startDate":"2024-02-19","conditions":"Palliative Care","enrollment":10},{"nctId":"NCT07257978","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Fenix Innovation Group","startDate":"2026-07-01","conditions":"RETT Syndrome With Proven MECP2 Mutation, Rett Syndrome","enrollment":40},{"nctId":"NCT07257939","phase":"PHASE3","title":"NTI164 in Autism Spectrum Disorder","status":"NOT_YET_RECRUITING","sponsor":"Fenix Innovation Group","startDate":"2026-07-01","conditions":"Autism, Autism Spectrum Disorder, Autism Disorder","enrollment":98},{"nctId":"NCT05554146","phase":"NA","title":"Pain Inflammation and Cannabis in HIV","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2022-10-28","conditions":"HIV Infections, Neuropathic Pain, Cannabis","enrollment":35},{"nctId":"NCT04827992","phase":"NA","title":"Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2021-08-23","conditions":"Opioid Use, Pain, Marijuana Use","enrollment":87},{"nctId":"NCT07217730","phase":"","title":"Healthcare Integrity & Anti-Fraud Enforcement","status":"ENROLLING_BY_INVITATION","sponsor":"Truway Health, Inc.","startDate":"2025-10-13","conditions":"Healthcare Fraud Schemes, Kickback Networks, Supply Chain Vulnerabilities","enrollment":100},{"nctId":"NCT07194928","phase":"","title":"Medical Cannabis as an Opiate Alternative","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2024-10-11","conditions":"Chronic Pain, Opioid Use","enrollment":29},{"nctId":"NCT07183254","phase":"NA","title":"Resting-state Imaging and Chronic Consumption of Non-Nutritive SweetenerS","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2025-10-01","conditions":"Healthy Volunteers - Male and Female","enrollment":100},{"nctId":"NCT07168707","phase":"NA","title":"Culturally Adapted EAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Pilot Study","status":"RECRUITING","sponsor":"Reuth Rehabilitation Hospital","startDate":"2025-07-09","conditions":"Chronic Musculoskeletal Pain, Cannabis Use","enrollment":8},{"nctId":"NCT03948074","phase":"PHASE2","title":"Cannabis For Cancer-Related Symptoms","status":"COMPLETED","sponsor":"Pippa Hawley","startDate":"2021-02-01","conditions":"Pain, Nausea, Anxiety","enrollment":91},{"nctId":"NCT07107607","phase":"","title":"Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)","status":"RECRUITING","sponsor":"HealthPartners Institute","startDate":"2021-03-19","conditions":"Cancer, Cancer (With or Without Metastasis)","enrollment":50},{"nctId":"NCT06605430","phase":"PHASE2","title":"Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer","status":"RECRUITING","sponsor":"HealthPartners Institute","startDate":"2024-09-16","conditions":"Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic","enrollment":64},{"nctId":"NCT04526093","phase":"","title":"Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2020-07-15","conditions":"Pain, Sleep, Anxiety","enrollment":1000},{"nctId":"NCT06808048","phase":"NA","title":"Medical Cannabis and Behavior","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2025-06-18","conditions":"Chronic Pain Patients, Medical Cannabis Users","enrollment":180},{"nctId":"NCT06358144","phase":"NA","title":"Cannabis Edibles Packaging Imagery Experiment","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2024-05-23","conditions":"Cannabis Use","enrollment":1260},{"nctId":"NCT06995937","phase":"","title":"Medical Marijuana and Open Road Driving Task","status":"RECRUITING","sponsor":"Florida State University","startDate":"2025-05-19","conditions":"Medical Cannabis","enrollment":250},{"nctId":"NCT05337033","phase":"PHASE2","title":"Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2024-10-11","conditions":"Chronic Migraine","enrollment":20},{"nctId":"NCT05132842","phase":"","title":"Cannabis Use Patterns Among Cancer Patients","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2021-02-25","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":1568},{"nctId":"NCT06490445","phase":"PHASE2","title":"A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)","status":"RECRUITING","sponsor":"Syqe Medical","startDate":"2024-11-14","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":192},{"nctId":"NCT01730781","phase":"","title":"Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning","status":"RECRUITING","sponsor":"Yale University","startDate":"2010-07","conditions":"Schizophrenia, Cannabis Dependence, Prodromal for Psychotic Illness","enrollment":100},{"nctId":"NCT05430490","phase":"","title":"Cannabis, HIV and Mental Processing Systems","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2022-03-23","conditions":"HIV Infections, Cannabis","enrollment":320},{"nctId":"NCT06903624","phase":"","title":"Cannabis in Postoperative Pain Management","status":"COMPLETED","sponsor":"Assuta Medical Center","startDate":"2016-01-01","conditions":"Postoperative Pain","enrollment":70000},{"nctId":"NCT04629716","phase":"","title":"Reactions of Older Adults Driving After Cannabis Exposure","status":"COMPLETED","sponsor":"Florida State University","startDate":"2021-04-23","conditions":"Chronic Pain","enrollment":44},{"nctId":"NCT06713447","phase":"PHASE1","title":"NTI164 Human PK Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fenix Innovation Group","startDate":"2024-02-01","conditions":"Healthy, Healthy Volunteer","enrollment":12},{"nctId":"NCT03984565","phase":"PHASE2","title":"PAIN: a Project Assessing the Impact of a Novel Cannabinoid Product","status":"RECRUITING","sponsor":"Staci Gruber, Ph.D.","startDate":"2024-06-27","conditions":"Chronic Pain","enrollment":25},{"nctId":"NCT06432400","phase":"NA","title":"Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders","status":"WITHDRAWN","sponsor":"Hôpital NOVO","startDate":"2024-12","conditions":"Trauma","enrollment":""},{"nctId":"NCT06206252","phase":"","title":"Can Medical Cannabis Affect Opioid Use?","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2023-09-07","conditions":"Chronic Pain, Pain","enrollment":110},{"nctId":"NCT05432206","phase":"PHASE2, PHASE3","title":"MEDical CANnabis for Improving Symptoms During Severe DEMentia Disorders in Long-term Care Facility in Geneva","status":"COMPLETED","sponsor":"Fondation pour l'accueil et l'hébérement des personnes âgées","startDate":"2023-09-29","conditions":"Dementia with Behavioral Disturbance","enrollment":27},{"nctId":"NCT05092191","phase":"PHASE2","title":"Cannabis as a Complementary Treatment in Multiple Sclerosis","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2022-11-10","conditions":"Multiple Sclerosis","enrollment":250},{"nctId":"NCT03337503","phase":"PHASE2","title":"Safety and Efficacy of Medical Cannabis Oil in the Treatment of Patients with Chronic Pain","status":"TERMINATED","sponsor":"Santé Cannabis","startDate":"2018-01-29","conditions":"Chronic Pain","enrollment":161},{"nctId":"NCT05184478","phase":"PHASE1, PHASE2","title":"Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? a Pilot Study","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-05-16","conditions":"Tourette Syndrome in Adolescence","enrollment":10},{"nctId":"NCT03233633","phase":"PHASE1","title":"Marijuana in Combination With Opioids in Palliative and Hospice Patients","status":"COMPLETED","sponsor":"The Connecticut Hospice Inc.","startDate":"2017-05-10","conditions":"Pain","enrollment":66},{"nctId":"NCT06249542","phase":"NA","title":"Implementing Screening for Cannabis and Other Drug Use Disorders in Primary Care: Impact on Diagnosis and Treatment","status":"COMPLETED","sponsor":"Kaiser Permanente","startDate":"2015-01","conditions":"Cannabis-Related Disorder, Cannabis Abuse, Drug Abuse","enrollment":363936},{"nctId":"NCT06655961","phase":"NA","title":"The Effect of Gardening Activities on Anxiety and Psychosocial Symptoms of Hospitalized Children","status":"NOT_YET_RECRUITING","sponsor":"Tokat Gaziosmanpasa University","startDate":"2024-12","conditions":"Gardening, Pediatric Nursing, Activity","enrollment":36},{"nctId":"NCT06098573","phase":"NA","title":"Development and Evaluation of HighAlert","status":"COMPLETED","sponsor":"Western University, Canada","startDate":"2023-11-01","conditions":"Cannabis, Youth Drinking","enrollment":103},{"nctId":"NCT06640712","phase":"NA","title":"Oral and Dental Health in Substance Dependent Individuals","status":"COMPLETED","sponsor":"Izmir Democracy University","startDate":"2024-04-25","conditions":"Substance Use Disorder (SUD), Decayed Teeth, Teeth Loss","enrollment":281},{"nctId":"NCT06621888","phase":"PHASE1, PHASE2","title":"Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fenix Innovation Group","startDate":"2023-06-02","conditions":"PANS Pediatric Acute-Onset Neuropsychiatric Syndrome","enrollment":18},{"nctId":"NCT06621043","phase":"PHASE1, PHASE2","title":"Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fenix Innovation Group","startDate":"2023-09-20","conditions":"Rett Syndrome","enrollment":14},{"nctId":"NCT06597097","phase":"","title":"Evaluation of Interprofessional Relations Between Primary Care and Hospital Centers in the Experimentation of Medical Cannabis in France Carried Out by the ANSM (ECIPCanna)","status":"ENROLLING_BY_INVITATION","sponsor":"University Hospital, Brest","startDate":"2024-10-01","conditions":"Medical Cannabis","enrollment":108},{"nctId":"NCT03052738","phase":"","title":"Medical Marijuana in the Pediatric Central Nervous System Tumor Population","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2016-01-15","conditions":"Central Nervous System Tumor, Brain Tumor, Spinal Tumor","enrollment":19},{"nctId":"NCT06542445","phase":"PHASE2","title":"The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD","status":"RECRUITING","sponsor":"Bazelet Nehushtan LtD.","startDate":"2024-08-22","conditions":"Attention Deficit Hyperactivity Disorder (ADHD)","enrollment":120},{"nctId":"NCT05212493","phase":"PHASE3","title":"The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder","status":"COMPLETED","sponsor":"Assaf-Harofeh Medical Center","startDate":"2019-11-14","conditions":"Autism Spectrum Disorder","enrollment":128},{"nctId":"NCT06526208","phase":"PHASE2","title":"Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults","status":"NOT_YET_RECRUITING","sponsor":"Southwest Autism Research & Resource Center","startDate":"2024-10-01","conditions":"Autism Spectrum Disorder, Anxiety","enrollment":108},{"nctId":"NCT06518434","phase":"PHASE2","title":"A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients","status":"RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2021-04-15","conditions":"Hepatocellular Carcinoma, Cannabis","enrollment":20},{"nctId":"NCT04226690","phase":"PHASE1","title":"Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products","status":"COMPLETED","sponsor":"Yale University","startDate":"2022-11-15","conditions":"Pain","enrollment":24},{"nctId":"NCT06217146","phase":"NA","title":"A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.","status":"TERMINATED","sponsor":"M. H MediCane Ltd.","startDate":"2022-10-12","conditions":"Agitation,Psychomotor, Disruptive Behavior, Dementia","enrollment":24},{"nctId":"NCT04634136","phase":"NA","title":"Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2020-10-15","conditions":"Children, Adult, Spastic Cerebral Palsy, Quality of Life","enrollment":55},{"nctId":"NCT06417827","phase":"NA","title":"Artificial Intelligence for Mental Health Diagnoses and Treatment Plans: A Protocol for Actors and Patients","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2023-12-12","conditions":"Mental Health Diagnosis","enrollment":220},{"nctId":"NCT04308148","phase":"","title":"Does Medical Cannabis Reduce Opioid Use in Adults With Pain","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2020-10-06","conditions":"Opioid Use, Marijuana, Chronic Pain","enrollment":217},{"nctId":"NCT05344170","phase":"PHASE1, PHASE2","title":"Cannabinol Use in Patients With Insomnia Disorder","status":"COMPLETED","sponsor":"Woolcock Institute of Medical Research","startDate":"2022-08-24","conditions":"Insomnia Disorder","enrollment":20},{"nctId":"NCT06213064","phase":"","title":"A Direct-to-Consumer Study Investigating the Effect of Specific Cannabinoid Products on Motivation, Energy Level, Focus, and Appetite in Healthy Adults","status":"UNKNOWN","sponsor":"Phylos Bioscience, Inc.","startDate":"2023-08-14","conditions":"Motivation","enrollment":58},{"nctId":"NCT03245658","phase":"PHASE2","title":"The Effect of Cannabis in Pancreatic Cancer","status":"WITHDRAWN","sponsor":"Jens Rikardt Andersen","startDate":"2017-10-06","conditions":"Neoplasms Pancreatic, Cachexia; Cancer, Cannabis","enrollment":""},{"nctId":"NCT05731687","phase":"NA","title":"Bifurcation PCI With a Hybrid Strategy With Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy","status":"RECRUITING","sponsor":"Cathreine BV","startDate":"2023-03-21","conditions":"Coronary Artery Disease, Coronary Bifurcation Lesion","enrollment":500},{"nctId":"NCT05863910","phase":"","title":"Real World Evidence on the Use of Medical Cannabis in Pediatrics","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-11-20","conditions":"Cancer, Epilepsy, Neurodevelopmental Disorders","enrollment":500},{"nctId":"NCT03224468","phase":"NA","title":"Effect of Medical Marijuana on Neurocognition and Escalation of Use","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-07-01","conditions":"Pain, Insomnia, Depression","enrollment":269},{"nctId":"NCT03268551","phase":"","title":"MEMO-Medical Marijuana and Opioids Study","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-09-04","conditions":"Opioid Use, Marijuana, Chronic Pain","enrollment":257},{"nctId":"NCT04923230","phase":"NA","title":"Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse","status":"COMPLETED","sponsor":"Oregon Research Institute","startDate":"2021-06-01","conditions":"Cannabis Use Disorder, Mild, Cannabis Use Disorder, Moderate","enrollment":120},{"nctId":"NCT05939466","phase":"PHASE4","title":"Medical Cannabis for Treating Pain Related to Fibromyalgia","status":"COMPLETED","sponsor":"Universita degli Studi della Basilicata","startDate":"2021-03-01","conditions":"Fibromyalgia","enrollment":30},{"nctId":"NCT03024827","phase":"PHASE1","title":"Cannabidiol in Children With Refractory Epileptic Encephalopathy","status":"UNKNOWN","sponsor":"University of Saskatchewan","startDate":"2017-04-26","conditions":"Epileptic Encephalopathy","enrollment":20},{"nctId":"NCT05219370","phase":"PHASE2","title":"Treatment With Cannabis Oil Containing CBD, THC, CBDV or CBG vs. Placebo of Persons With ADHD","status":"TERMINATED","sponsor":"Brlev Agricultural Crops Ltd","startDate":"2022-07-31","conditions":"ADHD, Hyperactivity, Attention Deficit","enrollment":8},{"nctId":"NCT04997954","phase":"PHASE4","title":"EMERALD TRIAL Open Label Extension Study","status":"UNKNOWN","sponsor":"Gold Coast Hospital and Health Service","startDate":"2021-05-17","conditions":"Amyotrophic Lateral Sclerosis, Cannabis, CBD","enrollment":7},{"nctId":"NCT04997395","phase":"PHASE2","title":"Feasibility of Cannabidiol for the Treatment of Long COVID","status":"COMPLETED","sponsor":"Bod Australia","startDate":"2022-04-14","conditions":"Long COVID","enrollment":12},{"nctId":"NCT04261166","phase":"PHASE1","title":"A Phase I Open Label Study to Assess PK and Safety of Plant Cannabis Extract","status":"COMPLETED","sponsor":"Breath of Life International Pharma Ltd","startDate":"2019-07-24","conditions":"Healthy","enrollment":76},{"nctId":"NCT05626959","phase":"PHASE2, PHASE3","title":"Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder","status":"UNKNOWN","sponsor":"Fenix Innovation Group","startDate":"2022-11-30","conditions":"Autism Spectrum Disorder","enrollment":54},{"nctId":"NCT04971629","phase":"","title":"The Relationship Between Cannabis Use, Biomarkers, Tissue Cannabinoid Levels and Clinical Outcomes in Patients With OA","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2021-07-13","conditions":"Osteo Arthritis Knee","enrollment":1200},{"nctId":"NCT05578313","phase":"","title":"Inflammatory Bowel Diseases (IBD) Cannabis Registry","status":"UNKNOWN","sponsor":"Eli Sprecher, MD","startDate":"2019-07-10","conditions":"Crohn Disease, Ulcerative Colitis, Pouchitis","enrollment":1000},{"nctId":"NCT05516823","phase":"","title":"Personality and Drug Use","status":"UNKNOWN","sponsor":"Psychedelic Data Society","startDate":"2022-11","conditions":"No Conditions Study Focus on Substance Use and Personality","enrollment":1000},{"nctId":"NCT04860089","phase":"","title":"Pain, Inflammation, and Cannabis in HIV","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2022-08","conditions":"HIV Infections, Neuropathic Pain, Cannabis","enrollment":""},{"nctId":"NCT03964974","phase":"NA","title":"Reducing Cannabis Use for Sleep Among Adults Using Medical Cannabis","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2020-02-10","conditions":"Insomnia Chronic, Cannabis Use","enrollment":57},{"nctId":"NCT05516407","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder.","status":"UNKNOWN","sponsor":"Fenix Innovation Group","startDate":"2021-04-01","conditions":"Autism Spectrum Disorder","enrollment":18},{"nctId":"NCT04976738","phase":"PHASE1, PHASE2","title":"A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain","status":"COMPLETED","sponsor":"Cymra Life Sciences","startDate":"2021-09-20","conditions":"Chronic Pain, Neck Pain, Back Pain","enrollment":28},{"nctId":"NCT05413187","phase":"PHASE2","title":"A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder","status":"WITHDRAWN","sponsor":"TO Pharmaceuticals","startDate":"2020-09-01","conditions":"Autistic Disorder","enrollment":""},{"nctId":"NCT03944447","phase":"PHASE2","title":"Outcomes Mandate National Integration With Cannabis as Medicine","status":"UNKNOWN","sponsor":"OMNI Medical Services, LLC","startDate":"2018-12-01","conditions":"Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury","enrollment":200000},{"nctId":"NCT05180149","phase":"","title":"Personality and Drug Use (PDU)","status":"WITHDRAWN","sponsor":"Quantified Citizen Technologies Inc.","startDate":"2022-04","conditions":"Personality","enrollment":""},{"nctId":"NCT04376437","phase":"NA","title":"The Kinetics of Endocannabinoids in Patients With Chemotherapy Induced Peripheral Neuropathy by Using Medical Cannabis.","status":"UNKNOWN","sponsor":"HaEmek Medical Center, Israel","startDate":"2022-03-15","conditions":"Chemotherapy-induced Peripheral Neuropathy","enrollment":40},{"nctId":"NCT05247411","phase":"NA","title":"Nurse Educational Intervention to Improve Symptoms in Fibromyalgia Patients","status":"COMPLETED","sponsor":"University of Milano Bicocca","startDate":"2020-07-15","conditions":"Fibromyalgia","enrollment":30},{"nctId":"NCT05235503","phase":"PHASE4","title":"Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2021-12-09","conditions":"Respiratory Depression, Cannabis Use, Opioid Use","enrollment":20},{"nctId":"NCT05210660","phase":"","title":"Medical Cannabis Against Chronic Musculoskeletal Pain: a Mixed Methods Study.","status":"UNKNOWN","sponsor":"CHU de Quebec-Universite Laval","startDate":"2020-01-21","conditions":"Musculoskeletal Pain, Cannabis Use","enrollment":45},{"nctId":"NCT03483220","phase":"","title":"Emotional Regulation, Impulsivity in Cannabis Its Relation to MRI Brain Structure","status":"COMPLETED","sponsor":"Assiut University","startDate":"2021-03-01","conditions":"Addiction","enrollment":66},{"nctId":"NCT05115318","phase":"","title":"The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette Syndrome","status":"COMPLETED","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2020-07-01","conditions":"Tourette Syndrome, Cannabis","enrollment":18},{"nctId":"NCT05106504","phase":"","title":"Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's Disease","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2021-09-02","conditions":"Bladder, Overactive, Parkinson Disease","enrollment":100},{"nctId":"NCT04945031","phase":"","title":"The Study of Pharmacological Treatment Pattern for Cannabis-induced Psychosis","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2019-11-08","conditions":"Cannabis","enrollment":317},{"nctId":"NCT04402554","phase":"","title":"Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis","status":"COMPLETED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2020-05-19","conditions":"Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis","enrollment":501},{"nctId":"NCT04841993","phase":"PHASE1","title":"Pharmacokinetics and Pharmacological Effects of a Standardized Cannabis Preparation","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2018-12-10","conditions":"Cannabis Use, Healthy Subjects","enrollment":43},{"nctId":"NCT03247244","phase":"PHASE2","title":"Safety and Efficacy of Cannabis in Tourette Syndrome","status":"TERMINATED","sponsor":"University Health Network, Toronto","startDate":"2018-01-15","conditions":"Tourette Syndrome","enrollment":15},{"nctId":"NCT03808935","phase":"PHASE3","title":"Cannabis Extract in Refractory Epilepsy Study","status":"TERMINATED","sponsor":"The Epilepsy Research Program of the Ontario Brain Institute","startDate":"2019-01-10","conditions":"Drug Resistant Epilepsy","enrollment":17},{"nctId":"NCT04031313","phase":"","title":"Effectiveness and Safety of Oil Extracts Medical Cannabis Treatment for Patients With Chronic Pain","status":"UNKNOWN","sponsor":"Dorit Pud","startDate":"2019-08-01","conditions":"Chronic Pain","enrollment":600},{"nctId":"NCT04316598","phase":"PHASE1","title":"Cannabis Effects on Electroencephalography","status":"TERMINATED","sponsor":"Parc de Salut Mar","startDate":"2020-03-03","conditions":"Healthy Volunteers","enrollment":16},{"nctId":"NCT03886753","phase":"","title":"Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products","status":"TERMINATED","sponsor":"Children's Hospital of Philadelphia","startDate":"2019-05-15","conditions":"ALS, Autism Spectrum Disorder, Cancer","enrollment":10},{"nctId":"NCT04083261","phase":"","title":"Pharmacogenetic Variation: Factors That May Affect the Efficacy and Safety of Medical Marijuana","status":"COMPLETED","sponsor":"Columbia Care Inc.","startDate":"2019-07-11","conditions":"New York Medical Marijuana Program Qualifying Conditions","enrollment":157}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"HOSPICE CARE"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Marijuana Medical","Marijuana Treatment"],"phase":"phase_2","status":"active","brandName":"Cannabis, Medical","genericName":"Cannabis, Medical","companyName":"OMNI Medical Services, LLC","companyId":"omni-medical-services-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Medical cannabis modulates the endocannabinoid system through cannabinoid receptors (CB1 and CB2) to produce therapeutic effects including pain relief, anti-inflammation, and symptom management. Used for Chronic pain, Chemotherapy-induced nausea and vomiting, Multiple sclerosis-related spasticity.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}